CRO Full-Service Capabilities

CTC is a full-service CRO with focus on early phase clinical trials. Our mission is to facilitate clinical and translational research by providing our customers with cost-effective advice, conduct and reporting of clinical trials.

We are capable of assuming full responsibility for your clinical development program, starting from the initial translation of preclinical data into the human setting and extending through Phase II. Our approach emphasises transparent collaboration and a cohesive partnership with our clients.

We perform in-house clinical conduct at our first-in-human (FIH) and Phase I-IV clinical research units in Uppsala, Stockholm, Linköping and Gothenburg. Our clinics work in close collaboration with our Clinical Operations, Biometrics, Pharmacovigilance and DMPK & Clinical Pharmacology departments to provide a true full-service option to our customers.

Phase 0

Phase I

• First-in-Human
  • Single Ascending Dose (SAD)
  • Multiple Ascending Dose (MAD)
• Food Interaction
• Drug-drug Interaction (DDI)
• Bioavailability and Bioequivalence
• Pharmakokinetics/Pharmacodynamics (PK/PD)
• TQT studies
• ADME Studies
• Hepatic impairment
• Renal impairment

Phase II

• Proof-of-Concept, Efficacy or Mechanism
• Dose Finding
• Multi-centre

Medical Device

• Pilot/First-in-Human
• Early and Traditional Feasibility
• User Testing

Other study types

• Functional foods
• Nicotine Based Products